• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Empowerment of athletes with cardiac disorders: a new paradigm.赋予患有心脏疾病的运动员权力:一种新的范式。
Europace. 2018 Aug 1;20(8):1243-1251. doi: 10.1093/europace/eux268.
2
Stages of psychological impact after diagnosis with serious or potentially lethal cardiac disease in young competitive athletes: a new model.年轻竞技运动员被诊断出患有严重或潜在致命性心脏病后的心理影响阶段:一种新模式
J Electrocardiol. 2015 May-Jun;48(3):298-310. doi: 10.1016/j.jelectrocard.2014.12.018. Epub 2015 Jan 3.
3
Return to play with hypertrophic cardiomyopathy: are we moving too fast? A critical review.重返赛场与肥厚型心肌病:我们是否操之过急?批判性评价。
Br J Sports Med. 2021 Sep;55(18):1041-1047. doi: 10.1136/bjsports-2020-102921. Epub 2021 Jan 20.
4
Legal responsibilities of physicians when making participation decisions in athletes with cardiac disorders: Do guidelines provide a solid legal footing?医生在做出患有心脏疾病运动员的参赛决策时的法律责任:指南是否提供了坚实的法律依据?
Br J Sports Med. 2014 Aug;48(15):1193-5. doi: 10.1136/bjsports-2013-093023. Epub 2014 Mar 25.
5
Making prudent recommendations for return-to-play in adult athletes with cardiac conditions.为患有心脏疾病的成年运动员重返赛场提供谨慎的建议。
Curr Sports Med Rep. 2011 Mar-Apr;10(2):65-77. doi: 10.1249/JSR.0b013e3182159a55.
6
A legal perspective on athlete screening and disqualification.运动员筛查与取消资格的法律视角
Cardiol Young. 2017 Jan;27(S1):S104-S109. doi: 10.1017/S1047951116002328.
7
MY APPROACH to the athlete with hypertrophic cardiomyopathy.我对肥厚型心肌病运动员的治疗方法。
Trends Cardiovasc Med. 2019 Jul;29(5):312. doi: 10.1016/j.tcm.2018.10.014. Epub 2018 Nov 2.
8
Impact of exercise addiction on attitude to preparticipation evaluation and adherence to medical prescription.运动成瘾对参赛前评估态度和遵医嘱的影响。
J Cardiovasc Med (Hagerstown). 2020 Oct;21(10):772-778. doi: 10.2459/JCM.0000000000000997.
9
Competitive Sport Participation Among Athletes With Heart Disease: A Call for a Paradigm Shift in Decision Making.心脏病运动员参与竞技运动:呼吁决策模式转变
Circulation. 2017 Oct 24;136(17):1569-1571. doi: 10.1161/CIRCULATIONAHA.117.029639.
10
[Heart and sports: when can it be dangerous?].[心脏与运动:何时会有危险?]
Praxis (Bern 1994). 2007 Dec 19;96(51-52):2041-6. doi: 10.1024/1661-8157.96.51.2041.

引用本文的文献

1
Sudden Cardiac Arrest in Athletes: A Primary Level of Prevention.运动员心搏骤停:一级预防水平
Cureus. 2022 Oct 20;14(10):e30517. doi: 10.7759/cureus.30517. eCollection 2022 Oct.
2
Cardiopulmonary Resuscitation and Defibrillator Use in Sports.体育运动中的心肺复苏与除颤器使用
Front Cardiovasc Med. 2022 Feb 15;9:819609. doi: 10.3389/fcvm.2022.819609. eCollection 2022.
3
Exercise and Atrial Fibrillation: Some Good News and Some Bad News.运动与心房颤动:一些好消息和一些坏消息。
Galen Med J. 2018 Nov 8;7:e1401. doi: 10.22086/gmj.v0i0.1401. eCollection 2018.
4
Long-QT Syndrome and Competitive Sports.长QT综合征与竞技运动
Arrhythm Electrophysiol Rev. 2018 Aug;7(3):187-192. doi: 10.15420/aer.2018.39.3.

本文引用的文献

1
Competitive Sports Participation in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia: A Single Center's Early Experience.儿茶酚胺能多形性室性心动过速患者参与竞技运动:单中心的早期经验
JACC Clin Electrophysiol. 2016 Jun;2(3):253-262. doi: 10.1016/j.jacep.2016.01.020. Epub 2016 Jun 20.
2
Call for joint informed consent in athletes with inherited cardiac conditions.呼吁对患有遗传性心脏病的运动员实行联合知情同意。
Open Heart. 2017 Jan 30;4(1):e000516. doi: 10.1136/openhrt-2016-000516. eCollection 2017.
3
Is it time to loosen the restrictions on athletes with cardiac disorders competing in sport?是时候放宽对患有心脏疾病的运动员参加体育比赛的限制了吗?
Br J Sports Med. 2017 Jul;51(14):1056-1057. doi: 10.1136/bjsports-2016-097002. Epub 2017 Apr 28.
4
Effect of Moderate-Intensity Exercise Training on Peak Oxygen Consumption in Patients With Hypertrophic Cardiomyopathy: A Randomized Clinical Trial.中等强度运动训练对肥厚型心肌病患者峰值摄氧量的影响:一项随机临床试验。
JAMA. 2017 Apr 4;317(13):1349-1357. doi: 10.1001/jama.2017.2503.
5
Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE.运动参与者的赛前心血管评估以预防猝死:欧洲心律协会(EHRA)和欧洲心血管预防与康复协会(EACPR)的立场文件,欧洲心脏病学会(ESC)下属分支机构。得到亚太心脏节律学会(APHRS)、心脏节律学会(HRS)和拉丁美洲心脏节律学会(SOLAECE)认可。
Europace. 2017 Jan;19(1):139-163. doi: 10.1093/europace/euw243. Epub 2016 Nov 4.
6
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.2016年欧洲心脏病学会(ESC)与欧洲心胸外科学会(EACTS)合作制定的心房颤动管理指南。
Europace. 2016 Nov;18(11):1609-1678. doi: 10.1093/europace/euw295. Epub 2016 Aug 27.
7
Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 12: Emergency Action Plans, Resuscitation, Cardiopulmonary Resuscitation, and Automated External Defibrillators: A Scientific Statement From the American Heart Association and American College of Cardiology.心血管异常竞技运动员的资格认定与取消资格建议:特别工作组12:应急预案、复苏、心肺复苏及自动体外除颤器:美国心脏协会和美国心脏病学会的科学声明
Circulation. 2015 Dec 1;132(22):e334-8. doi: 10.1161/CIR.0000000000000248. Epub 2015 Nov 2.
8
Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Preamble, Principles, and General Considerations: A Scientific Statement From the American Heart Association and American College of Cardiology.心血管异常竞技运动员的资格与取消资格建议:前言、原则及一般考量:美国心脏协会和美国心脏病学会的科学声明
Circulation. 2015 Dec 1;132(22):e256-61. doi: 10.1161/CIR.0000000000000236. Epub 2015 Nov 2.
9
Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 9: Arrhythmias and Conduction Defects: A Scientific Statement From the American Heart Association and American College of Cardiology.心血管异常竞技运动员的资格认定与取消资格建议:特别工作组9:心律失常与传导缺陷:美国心脏协会和美国心脏病学会的科学声明
J Am Coll Cardiol. 2015 Dec 1;66(21):2412-2423. doi: 10.1016/j.jacc.2015.09.041. Epub 2015 Nov 2.
10
Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology.心血管异常竞技运动员的资格认定与取消资格建议:特别工作组3:肥厚型心肌病、致心律失常性右室心肌病及其他心肌病、心肌炎:美国心脏协会和美国心脏病学会科学声明
J Am Coll Cardiol. 2015 Dec 1;66(21):2362-2371. doi: 10.1016/j.jacc.2015.09.035. Epub 2015 Nov 2.

赋予患有心脏疾病的运动员权力:一种新的范式。

Empowerment of athletes with cardiac disorders: a new paradigm.

机构信息

Farr Institute of Health Informatics, University College London, London, UK.

Barts Heart Centre, Barts Health NHS Trust, West Smithfield, London, UK.

出版信息

Europace. 2018 Aug 1;20(8):1243-1251. doi: 10.1093/europace/eux268.

DOI:10.1093/europace/eux268
PMID:29016796
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6075459/
Abstract

Athletes with cardiac disorders frequently pose an ethical and medical dilemma to physicians assessing their eligibility to participate in sport. In recent decades, patient empowerment has been gaining increasing recognition in clinical decision-making. Empowerment is a process through which people are involved over the decisions and actions that affect their own lives. In the context of a cardiac disorder, empowerment means giving an athlete the chance to participate in the decision about whether or not to remain active in competition. Three models of treatment decision-making are described in this article, with progressive levels of empowerment: the paternalistic model (the athlete has a passive role), the shared-decision making model (both athlete and physician participate in the decision), and the informed-decision making (the decision is made by the athlete while the role of the physician is solely to provide information). This article critically discusses the issues involved in disqualification of athletes with cardiovascular disorders and suggests possible ways of incorporating patient empowerment in potentially career-ending decisions. The authors propose a model of empowerment, which gives patients the opportunity to choose how much, and if, they would like to be involved in the decision-making process.

摘要

患有心脏疾病的运动员经常给评估其参赛资格的医生带来伦理和医学上的困境。近几十年来,患者赋权在临床决策中越来越受到重视。赋权是一个过程,通过这个过程,人们参与影响自己生活的决策和行动。在心脏疾病的背景下,赋权意味着给予运动员机会参与关于是否继续参加比赛的决策。本文描述了三种治疗决策模型,赋权程度逐渐增加:家长式模型(运动员处于被动角色)、共享决策模型(运动员和医生都参与决策)和知情决策模型(决策由运动员做出,而医生的角色仅在于提供信息)。本文批判性地讨论了因心血管疾病而取消运动员参赛资格所涉及的问题,并提出了在可能终结职业生涯的决策中纳入患者赋权的可能方法。作者提出了一种赋权模式,为患者提供了选择参与决策过程的程度和是否参与的机会。